Table 3.
Effect Sizes on Outcome Measures for Intent-to-Treat and Completer Analyses
| Post-treatment |
Follow up |
||||
|---|---|---|---|---|---|
| WL (pre to post)a |
CT-PTSD (pre to post)a |
CT-PTSD vs WL (post)b |
CT-PTSD (pre to 6MFU)a |
CT-PTSD (pre to 12MFU)a |
|
| Intent-to-treat | |||||
| PTSD symptoms (CPTSDI) | .48 | 2.78 | 2.01 | 3.55 | 2.86 |
| PTSD severity (CPSS) | .53 | 2.65 | 1.23 | 3.21 | 3.63 |
| Depression (MFQ) | .11 | 1.43 | .84 | 1.59 | 2.17 |
| Anxiety (SCAS) | .25 | 1.40 | 1.56 | 1.70 | 2.09 |
| Functioning (CGAS) | -.23 | 1.73 | 1.58 | ||
| Emotional problems (SDQ) | .07 | 1.20 | 1.02 | ||
| Conduct problems (SDQ) | -.07 | .56 | 1.20 | ||
| Hyperactivity (SDQ) | -.09 | .92 | 1.51 | ||
| Completer | |||||
| PTSD symptoms (CPTSDI) | .43 | 2.71 | 1.91 | 3.54 | 2.85 |
| PTSD severity (CPSS) | .41 | 2.68 | 1.34 | 3.15 | 3.63 |
| Depression (MFQ) | .14 | 1.41 | .77 | 1.60 | 2.20 |
| Anxiety (SCAS) | .15 | 1.43 | 1.09 | 1.74 | 2.12 |
| Functioning (CGAS) | -.27 | 1.71 | 1.58 | ||
| Emotional problems (SDQ) | .21 | 1.11 | .82 | ||
| Conduct problems (SDQ) | -.06 | .61 | 1.12 | ||
| Hyperactivity (SDQ) | .03 | .77 | 1.26 | ||
Note.
a
Within-group; negative scores indicate worsening symptomatology/functioning.
b
Between-group; positive scores indicate superiority of CT-PTSD. Pre=pre-treatment (i.e. at randomisation); Post=post-CT-PTSD/WL (week 11); 6MFU=six month follow-up; 12MFU=12 month follow up.